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sets a heterogeneity within these cells,
through a non-canonical nuclear mode of
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Throughout life, adult neural stem cells (NSCs) pro-
duce new neurons and glia that contribute to crucial
brain functions. Quiescence is an essential protec-
tive feature of adult NSCs; however, the establish-
ment and maintenance of this state remain poorly
understood. We demonstrate that in the adult zebra-
fish pallium, the brain-enriched miR-9 is expressed
exclusively in a subset of quiescent NSCs, high-
lighting a heterogeneity within these cells, and is
necessary to maintain NSC quiescence. Strikingly,
miR-9, along with Argonaute proteins (Agos), is
localized to the nucleus of quiescent NSCs, and
manipulating their nuclear/cytoplasmic ratio impacts
quiescence. Mechanistically, miR-9 permits efficient
Notch signaling to promote quiescence, and we
identify the RISC protein TNRC6 as a mediator of
miR-9/Agos nuclear localization in vivo. We propose
a conserved non-canonical role for nuclear miR-9/
Agos in controlling the balance between NSC quies-
cence and activation, a key step in maintaining adult
germinal pools.
INTRODUCTION
Resident neural stem cells (NSCs) in the adult brain produce
new neurons and glia and display two fundamental features:
multipotency and long-term self-renewal capacity. Character-
ization of the adult neurogenesis process has shed light on
the importance of accurate NSCs control in brain homeostasis,
behavior, and brain repair/regeneration (Lim and Alvarez-
Buylla, 2014; Ming and Song, 2011). In the adult mouse brain,
NSCs are found primarily in two microenvironmental niches
located in the telencephalon: the subependymal zone (SEZ)
of the lateral ventricle and the subgranular zone (SGZ) of the
dentate gyrus of the hippocampus (Lim and Alvarez-Buylla,
2014). By contrast, in the zebrafish, which is emerging as anCell Re
This is an open access article under the CC BY-Nattractive comparative model, widespread neurogenesis is
maintained at adult stages in several brain regions (Adolf
et al., 2006; Grandel et al., 2006), including the dorsal telen-
cephalon (or pallium), which encompasses areas homologous
to the rodent SEZ and SGZ (Dirian et al., 2014). In this region,
radial glia cells (RG), constituting a large population that lines
the surface of the brain ventricle, have been identified as
NSCs (Figures S1A and S1B). These cells share features with
NSCs found in the mammalian brain including their radial
morphology, the expression of astroglial markers (GFAP, GS,
BLBP), and neurogenic stem cell markers (Sox2, Nestin,
Msi1, and the zebrafish Hes5 ortholog, her4) (Chapouton
et al., 2010; Ganz et al., 2010; Ma¨rz et al., 2010; Alunni et al.,
2013; Dirian et al., 2014; Than-Trong and Bally-Cuif, 2015).
Lineage tracing and clonal analyses have revealed that these
NSCs contribute to constitutive adult neurogenesis and are
able to self-renew and give rise to functional neurons at the sin-
gle cell level, both qualifying them as genuine stem cells and
demonstrating their robust neurogenic activity (Kroehne et al.,
2011; Rothenaigner et al., 2011).
A distinguishing feature of adult NSCs when compared with
embryonic neural progenitor cells (NPCs), both in zebrafish
and mammals, is their relative quiescence. Quiescence is a
reversible state of cell-cycle arrest, which is actively maintained
and involves profound alterations in cell physiology (Cheung and
Rando, 2013). Disrupting the balance between quiescent and
activated NSCs leads to a premature depletion or silencing of
long-lasting NSCs (Codega et al., 2014; Encinas et al., 2011;
Hsieh, 2012). Some key signaling or cell-cell interaction path-
ways, notably Notch and TGFb/BMP (Giachino and Taylor,
2014), have been identified in maintaining quiescence. In partic-
ular, in the zebrafish adult pallium, inhibiting Notch signaling
leads the entire population of NSCs to enter the cell cycle (Alunni
et al., 2013). Recent works further demonstrated that quiescent
NSCs are heterogeneous in their activation potential, their reac-
tivity to various stimuli and, once activated, their division rate and
ability to re-enter into quiescence (Hsieh, 2012; Lugert et al.,
2010). However, how quiescence cues are integrated to estab-
lish this cell state and the diversity within it have yet to be
assessed.ports 17, 1383–1398, October 25, 2016 ª 2016 The Authors. 1383
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
MicroRNAs are small regulatory RNAs that are known to post-
transcriptionally regulate gene expression via complementary
base pairing with mRNA targets (Bartel, 2009). Canonical micro-
RNA genes are transcribed into primary transcripts (pri-miRs)
containing a hairpin structure, which is cleaved out by the
nuclear microprocessor complex to give rise to a precursor
microRNA (pre-miR). Exportin 5 transports the pre-miR to the
cytoplasm where the RNase III enzyme Dicer processes it into
a mature microRNA duplex. The duplex is subsequently un-
wound, and one strand is preferentially integrated into the
RNA-induced silencing complex (RISC), which guides it to
mRNA targets. The RISC ismost notably composed of one Argo-
naute (Ago) effector protein, inside which themicroRNA strand is
loaded, and one GW182 protein (or TNRC6), which mediates
downstream steps in the cascade of microRNA-mediated gene
regulation (Meister, 2013). Because microRNAs can potentially
regulate hundreds of mRNA targets, they are generally thought
of as fine-tuners of gene expression, buffering or reinforcing
developmental and transitional states. Additionally, microRNA
levels and functions are influenced by both cell extrinsic and
intrinsic signals (Nam et al., 2014; Rissland et al., 2011). As
such, microRNAs are attractive candidates for integrating envi-
ronmental and internal cues in the regulation of NSCs quies-
cence/activation balance.
MicroRNA-9 (miR-9) is a highly conserved neural microRNA,
shown to be a determinant regulator of NPCs during vertebrate
embryonic development (Coolen et al., 2013). Expression of
miR-9-5p (the preferred mature strand in vertebrate embryos,
henceforth referred to simply as miR-9) is enriched to NPCs
and committed neuronal precursors in the proliferative ventricu-
lar zone (VZ); it promotes the transition of NPCs from a prolifer-
ative to a neurogenic mode and is crucial in the timing of their
cell-cycle exit (Leucht et al., 2008; Bonev et al., 2011; Shibata
et al., 2011; Coolen et al., 2012). Studies performed on mouse
NSCs proliferating in vitro also suggested that it could play a
similar role in adult NSCs dynamics (Zhao et al., 2009). To chal-
lenge this hypothesis in a physiological context in which adult
NSCs are mostly quiescent, we assessed here the role of
miR-9 in adult zebrafish NSCs in vivo. We show that miR-9
expression highlights a sub-state within the quiescence phase
of adult NSCs, and we demonstrate that it maintains quiescence
through potentiating Notch signaling activity. Remarkably, we
also find that miR-9 controls this key stem cell property via a
non-canonical nuclear mechanism.
RESULTS
miR-9 Is Expressed Exclusively in Quiescent Neural
Stem Cells in the Adult Telencephalon
To determine whether miR-9 could also control transitional
states in neural progenitors at late stages, we first assessed
the expression of the seven primary transcripts encoding
miR-9 (pri-miR-9) in embryonic, juvenile, and adult zebrafish
brains using qRT-PCR. We could detect the seven pri-miR-9
transcripts at all stages. However, there was a progressive
change in the respective contribution of the different transcripts
to the total pri-miR-9 pool (Figure 1A). We found that pri-miR-9-6
is the most predominantly expressed miR-9 transcript in the1384 Cell Reports 17, 1383–1398, October 25, 2016adult brain, in contrast to the situation in the embryo, where
pri-miR-9-2 is the most highly expressed. In situ hybridization
(ISH) experiments confirmed that pri-miR-9-6 is highly ex-
pressed in the adult telencephalon whereas pri-miR-9-2 is not
detectable (Figures 1B and S1C). Notably, pri-miR-9-6 expres-
sion appeared restricted to the first cellular row lining the brain
ventricle, composed of the radial glia (RG) that constitute the
population of NSCs in this region of the brain (Figure 1B).
To define the expression of miR-9 at a cellular resolution,
we performed fluorescent ISH experiments using an antisense
LNA probe specific for the mature miR-9 form in combination
with astroglial NSCs markers. In the zebrafish pallium, all RG
NSCs can faithfully be labeled by immunohistochemistry against
GFP in the gfap:gfp transgenic line or against glutamine synthase
(GS) (Figures S1A and S1B) (Chapouton et al., 2010; Alunni et al.,
2013). In contrast to mammals, astrocytes and ependymal cells
are absent from the zebrafish pallium, and the only cells that ex-
press these markers are RG NSCs (Than-Trong and Bally-Cuif,
2015). In line with the expression of pri-miR-9-6, we could detect
maturemiR-9 exclusively in RGNSCs (Figure 1C). To confirm the
specificity of the signal, we performed additional ISH using two
control LNA probes (a scrambled control probe and a probe anti-
sense to miR-9-3p) and two alternative LNA-modified 20-O-Me
RNA oligo probes (Søe et al., 2011) (one control and one
miR-9-specific probe). Altogether, these controls demonstrate
both the specificity of our miR-9 probe and the stringency of
our ISH protocol (Figures S1D and S1E) (LNA probes and their
sequences are listed in Table S2).
We next assessed the cycling status of miR-9-expressing
NSCs using cycling cell markers such as MCM5, MCM2, or
proliferating cell nuclear antigen (PCNA) that can be used inter-
changeably (Figures S1A and S1B) (Alunni et al., 2013; Chapou-
ton et al., 2006; Ma¨rz et al., 2010). Notably, miR-9-expressing
NSCs are almost always quiescent NSCs (qNSCs) (95% ± 2%)
(Figure 1C, red arrows), and we could validate a statistically sig-
nificant association between miR-9 expression and the quies-
cent state (c2 p value < 0.01) (Figures 1C and 1D). In addition,
and in contrast to all other NSC markers known to date, miR-9
was found to be expressed only in 47% ± 2% of the overall
qNSCs, highlighting a striking heterogeneity in this quiescent
population (Figure 1E).
miR-9 expression in a subpopulation of qNSCs could define a
distinct NSC sub-lineage, or rather a sub-state in the quiescence
cycle of all NSC. To investigate these hypotheses, we interro-
gated the dynamics of miR-9 expression in NSC in link with their
activation history.We applied a short pulse (2 hr) of the thymidine
analog bromodeoxyuridine (BrdU), which incorporates into the
DNA of dividing cells during S-phase, followed by chase periods
of increasing lengths from 1 to 30 days. We then analyzed the
expression of miR-9 among BrdU+ NSCs (Figures 1F–1H). After
1 day of chase, no miR-9 was detected in the BrdU+ NSCs (Fig-
ure 1H), consistent with the very rare presence of miR-9 expres-
sion in dividing glia (Figure 1D). After longer chase periods,miR-9
and BrdU double positive NSCs start to be apparent (Figure 1G,
yellow arrow, 1 hr), establishing that miR-9 can be expressed in
cells that had previously been actively cycling. The percentage of
BrdU+ NSCs expressing miR-9 gradually increased with chase
time, suggesting an asynchronous but progressive induction of
Figure 1. Dynamic Expression of miR-9 in qNSCs
(A) qRT-PCR analysis of the sevenmiR-9 transcripts in 48 hr post-fertilization (hpf) embryos, 1month post-fertilization (mpf) juvenile brains, and 3mpf adult brains
with the expression of each transcript over the sum expression of all transcripts.
(B) ISH against pri-miR-9-6 on a cross-section of the telencephalon illustrating its expression restricted to the ventricular region (blue). Scale bar, 100 mm.
(C) Sections through the medial region of the dorsal telencephalon showing ISH with a mature miR-9 LNA probe (magenta) and double fluorescent immuno-
staining for gfap:GFP (green) and MCM5 (light blue). miR-9 expression is restricted to qNSCs (gfap+, MCM5; red arrows) and never observed in aNSCs (gfap+,
MCM5+; white asterisk). Some qNSCs are devoid of miR-9 signal (yellow arrows). Scale bar, 10 mm.
(D) Proportion of qNSCs (gfap+, MCM5; dark gray) and aNSCs (gfap+, MCM5; light gray) in the total, miR-9+ or miR-9 NSC population demonstrating that
miR-9 expression is associated with quiescence.
(E) Percentage of qNSCs that are miR-9+ or miR-9.
(F) Experimental design to assess miR-9 expression dynamics across the NSCs activation/quiescence cycle.
(G) Representative image of BrdU+ (light blue), miR-9+ (pink), and GS+ (green) NSC 10 days after BrdU pulse. Scale bar, 5 mm.
(H) Percentage of miR-9+ cells among BrdU+ NSCs after different chase period. *p < 0.05; one-way ANOVA with Bonferroni post hoc correction. Data are
represented as mean ± 95% confidence interval (CI); n = 3 brains per condition.
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Figure 2. miR-9 Maintains NSC Quiescence
(A) Percentage of NSCs expressing miR-9 at 1, 2,
3, and 5 days post injection (dpi) of the control
vivoMO (light gray bars) or miR-9 vivoMO (dark
gray bars).
(B) Percentage of aNSCs (MCM5+, gfap) over
the total NSCs population (gfap+) 1, 2, 3, and 5 dpi
of the control vivoMO (light gray bars) or miR-9
vivoMO (dark gray bars).
(C) Double immunostaining for gfap:GFP (green)
and MCM5 (light blue) in control (top) and
miR-9 (bottom) vivoMO-injected brains. Scale
bar, 20 mm.
(D) Average raw number of gfap+ NSCs per section
in control (light gray bar) and miR-9 (dark gray bar)
vivoMO-treated brains at 5 dpi.
(E and F) Analysis of the fate of activated cells
upon miR-9 kd. Fish were administered BrdU for
48 hr following injection of vivoMOs and analyzed
after 30 days of chase. (E) Mean number of BrdU+
per brain section in control (light gray bar) and
miR-9 (dark gray bar) vivoMO-treated brains. (F)
Percentage of BrdU+ cells that remain NSCs
(gfap+), or acquired a neuronal fate (HuC/D+) or
other fate in control (light gray bar) andmiR-9 (dark
gray bar) vivoMO and brains after a 30 day chase.
*p < 0.05, **p < 0.01; one-way ANOVA with Bon-
ferroni post hoc correction. Data are represented
as mean ± 95% CI; n = 3 brains per condition.miR-9 expression among NSCs after cell division, to reach a
plateau at 50% (Figure 1H), matching the overall proportion
of qNSCs that express miR-9 (Figure 1E). Knowing that most
pallial NSCs are capable of dividing (Alunni et al., 2013), these
data together reveal that expression of miR-9 highlights a
specific sub-state of quiescence in which qNSCs dynamically
progress through.
miR-9 Maintains Quiescence
Does miR-9 actually play some role in controlling NSC quies-
cence? To address this issue, we performed loss-of-function
experiments. Vivo morpholino oligonucleotides (vivoMO) are
covalently linked to a delivery moiety conferring them the ability
to enter into a cell without the need for transfection. Injection
of a vivoMO into the brain ventricle enables the modulation of1386 Cell Reports 17, 1383–1398, October 25, 2016gene expression in the first ventricular
cell rows, most notably in the RG NSC
layer (Kizil and Brand, 2011). We used a
miR-9 antisense vivoMO that binds to
the mature miR-9 rendering it essentially
inactive. The sequence of this vivoMO is
identical to the MO previously validated
to efficiently inhibit miR-9 in zebrafish
embryos, without showing any evi-
dence for off-targets effects (Klooster-
man et al., 2007; Leucht et al., 2008)
(Table S1). By performing an ISH with
the mature miR-9 antisense probe, we
verified that the miR-9 vivoMO also effi-
ciently and specifically blocks miR-9 inthe adult pallium, for up to 3 days post injection (dpi) (Figures
2A and S2A). To determine the effect of miR-9 knockdown (kd)
we analyzed the ratios of NSC activation status by quantifying
GFAP+/MCM5 (qNSC) and GFAP+/MCM5+ (aNSC) in control
vivoMO- and miR-9 vivoMO-treated brains. In conditions of
miR-9 kd, we observed, on average, a 3-fold increase in the pro-
portion of aNSCs that was maintained for as long as the vivoMO
was active (Figures 2B and 2C). After 3 days of miR-9 kd,
this increase in aNSCs parallels the proportion of qNSCs that
endogenously express miR-9 demonstrating that almost all of
themiR-9 expressing NSCs enter into the cycle thus establishing
miR-9 as a potent regulator of quiescence. To confirm the spec-
ificity of the miR-9 vivoMO effect, we used a combination of
vivoMOs designed to target Drosha-processing sites on pre-
miR-9 sequences (processing MO1, MO6), thereby blocking
miR-9 production (Figure S2B; Table S1). Upon injection, these
morpholinos efficiently reduce mature miR-9 levels, both in
embryos and in the adult pallium (Figures S2C and S2D).
Consequently, and consistent with the effect of the vivoMO
targeted against mature miR-9, a significant increase in the
proportion of aNSCs is observed, confirming the specific ef-
fect of miR-9 kd on NSCs activation (Figure S2E). We also
verified that injections of vivoMOs do not induce any
apoptosis or inflammatory reaction, a process known to acti-
vate NSCs in the zebrafish pallium (Figure S2F) (Kizil et al.,
2012; Kyritsis et al., 2012), nor any induction of gata3 expres-
sion (Figure S2F), previously shown to mediate NSCs activa-
tion upon inflammation or lesion (Kizil et al., 2012; Kyritsis
et al., 2012). The increase in aNSCs observed upon miR-9
kd is thus not related to a regenerative response but rather
a consequence of an imbalance in constitutive neurogenesis
regulation.
Interestingly, at 5 dpi, the vivoMO appears to be no longer
active in blocking miR-9 (Figures 2A and S2A) and the prolifera-
tion rate of NSCs returns to basal levels (Figure 2B). Neverthe-
less, the NSCs activated upon miR-9 blockade proceed through
mitosis, as demonstrated by an increase in the total number of
RGNSCs lining the VZ at 5 dpi (Figure 2D), which is also in agree-
ment with most NSC divisions being symmetric in the short term
(Rothenaigner et al., 2011). To better appreciate the long-term
effect of miR-9 blockade on neurogenesis, we administered
BrdU for 48 hr after vivoMO injections and analyzed the fate of
dividing cells 30 days later by immunohistochemistry against
NSC and neuronal markers (GS and Hu, respectively). The raw
number of BrdU+ cells per section was doubled in the miR-9 viv-
oMO condition as compared to controls (Figure 2E), which
is consistent with the transient increase in proliferation we
observed in the short term. However, therewas no significant dif-
ference in the relative proportions of the different cell types
generated between the two conditions (Figure 2F). This shows
that upon miR-9 blockade, NSCs only increase their propensity
to enter the cell cycle, while their fate potential and clonal
behavior appear unchanged. Overall, these data reveal that the
primary role of miR-9 is maintaining quiescence of NSCs.
miR-9 Potentiates Notch Signaling to Promote
Quiescence
Zebrafish pallial NSC quiescence is maintained through active
Notch signaling (Chapouton et al., 2010; Alunni et al., 2013). To
investigate the relationship between miR-9 and Notch, we first
analyzed the effect of Notch blockade on miR-9 expression:
fishwere treated for 48 hr with LY411575 (LY), a potent derivative
of the g-secretase inhibitor DAPT, which efficiently blocks Notch
signaling and consequently pushes qNSCs into cell cycle re-en-
try (Figures S3A and S3B) (Alunni et al., 2013). qRT-PCR exper-
iments revealed that the levels of the seven pri-miR-9 transcripts
were not affected by Notch inhibition, in contrast to the direct
Notch target gene her4 (Figure 3A). Additionally, Notch inhibition
had no effect on mature miR-9 levels (Figure 3B), establishing
that miR-9 expression is not regulated by Notch in adult NSCs.
These results were surprising as inhibiting Notch using LY leads
to a significant increase in aNSCs and miR-9 is normally never
endogenously expressed in these cells (Figure 1D). To investi-gate this discrepancy, we analyzed the expression of miR-9 in
NSCs by ISH upon Notch blockade. In contrast to the control sit-
uation, we could observe miR-9 expression in PCNA+ cells that
were activated upon Notch blockade (Figure 3C, yellow arrow).
In fact, upon LY treatment, a similar proportion of activated cells
is observed among miR-9+ or miR-9 NSCs, and there is a loss
of the preferential association of miR-9 with the quiescent state
(DMSO: c2 p value < 0.05; LY: c2 p value = 0.87) (Figure 3D).
Downregulation of miR-9 is thus not an absolute requirement
for cell-cycle entry, at least in this context. Moreover, these
data demonstrate that when Notch signaling is impaired,
miR-9 is no longer able to inhibit cell-cycle entry thus suggesting
that miR-9 could act upstream of Notch in quiescence regula-
tion. In line with this idea, we observed that the expression of
the Notch effector her4 is downregulated upon miR-9 kd (Fig-
ure 3E), as well as the expression of another known Notch target
gene encoding the Notch-regulated ankyrin repeat protein
(nrarpa) (Figures S3D and S3E). By contrast, we do not observe
a concomitant decrease in the expression of the notch3 receptor
gene, the main notch receptor gene expressed in qNSCs (Alunni
et al., 2013) (Figure S3C). To further challenge our hypothesis, we
performed epistasis experiments in which we assessed the ef-
fect of miR-9 kd in NSCs with constitutively activate Notch
signaling. Ventricular NSCs were electroporated with an expres-
sion construct encoding a Myc-tagged Notch intracellular
domain (NICD) (Takke et al., 1999), followed by injection of the
miR-9 vivoMO. We observed that overexpression of NICD locks
NSCs in a quiescent state, as expected, and also erases the
activating effect of miR-9 depletion (Figure 3F). Altogether, our
results suggest that miR-9 maintains NSC quiescence by poten-
tiating Notch activation (Figure S3F).
miR-9 Is Concentrated in the Nucleus of Mature RG
NSCs and Is Strongly Associated with Nuclear
Localization of Ago Proteins
When analyzing the expression ofmiR-9 in the adult pallial NSCs,
we made the surprising observation that mature miR-9 mole-
cules were strongly concentrated in the nuclei of qNSCs
(Figure 4A, yellow arrow) (as stated previously, miR-9 is not
detectable in aNSCs) (Figure 4A, red arrow). This result was un-
expected, as canonically, mature microRNAs influence gene
expression via post-transcriptional regulation of mRNA in the
cytoplasm (Bartel, 2009). Importantly, we observed no nuclear
concentration of miR-9-3p in ventricular NSCs (Figure S1D)
thus arguing against a nuclear trapping of unprocessed pri-
miRs. In addition, we assessed the expression of another neuro-
genic microRNA, let-7b, whose expression pattern in the zebra-
fish embryo closely resembles that of miR-9 (Wienholds et al.,
2005). In the adult pallium, we found let-7b expression to be
localized to the first ventricular rows, encompassing RG cells
and differentiating neuronal precursors (Figure S4A); however,
in contrast to miR-9, let-7b localizes almost exclusively to the
cytoplasm (Figure S4A0). The localization of miR-9 in adult NSC
nuclei is also in complete contrast to the exclusively cytoplasmic
localization of miR-9 in embryonic or juvenile pallial neural pro-
genitors (NPCs) (Figure 4B). The specific nuclear enrichment
of mature miR-9 in adult NSCs compared to juvenile NSCs
was also confirmed by qRT-PCR on cytoplasmic and nuclearCell Reports 17, 1383–1398, October 25, 2016 1387
Figure 3. miR-9 Potentiates Notch Activity
to Maintain Quiescence
(A and B) Boxplots of qRT-PCR analysis
showing the relative change in expression of
the miR-9 transcripts and the Notch target her4
(A) and of the mature miR-9-5p/3p compared
to a U6 small nucleolar RNA (snoRNA) control
(B) after a 48 hr treatment with LY411575 or
DMSO (control). The top and the bottom of each
box indicate the 75th and 25th percentiles,
respectively, and the dotted line indicates the
median.
(C) Expression of miR-9 (magenta) in a GS+
(green)/PCNA+ (light blue) aNSC (yellow arrow)
after a 48 hr LY treatment. Scale bar, 5 mm.
(D) Proportion of qNSCs (gfap+, MCM5; dark
gray) and aNSCs (gfap+, MCM5+; white) in the
miR-9+ or miR-9 NSC population after a 48 hr
treatment with LY or DMSO.
(E) ISH for her4 2 dpi with the control (top) or miR-
9 (bottom) vivoMO. Right panels are close-ups of
the region within the red box. Scale bars, 100 mm
(left); 50 mm (right).
(F) Epistasis experiment combining miR-9 kd
with overexpression of Notch intracellular domain
(NICD). The graph shows the percentage of
qNSCs (dark gray) and aNSCs (white) in brains
injected with the control or miR-9 vivoMO and
in cells overexpressing NICD (NICD+) or not
(NICD). *p < 0.05, **p < 0.01; one-way ANOVA
with Bonferroni post hoc correction. Data are
represented as mean ± 95% CI; n = 3 brains
per condition.fractions (Figure S4B). These data reveal a switch in the subcel-
lular localization of miR-9, from the cytoplasm of NPCs to the
nucleus of mature qNSCs, further reinforcing a link between
miR-9 and a distinct quiescent state.
To assess the functional relevance of this observation, we
reasoned that active miR-9 should be loaded into Argonaute
proteins (Ago), the main effectors of the microRNA silencing
pathway (Meister, 2013), and therefore analyzed the subcellu-
lar localizationof Agoproteins in the zebrafishpallium.Weutilized
two independent Ago antibodies that recognize highly conserved
portions spanning the PIWI and most of the MID domains of hu-
man Ago2 (Figure S4C). Both detect a band at the expected
size in western blot (WB) from adult brain extracts, matching
the size of overexpressed zebrafish Flag-Ago2 (Figures S4D
and S4E, red arrows). Additionally, when performing immunohis-
tochemistry on adult NSCs electroporated in vivo with a Flag-
Ago2 expression construct, we observed overlapping signals1388 Cell Reports 17, 1383–1398, October 25, 2016for Flag and Ago (Figure S4G). As the
C-terminal portion is highly conserved
among all vertebrate Agos, however (Fig-
ure S4C), we cannot preclude that our an-
tibodies label other Ago proteins than
Ago2, and indeed, they have been shown
previously to detect other Agos (1, 3, and
4) in human samples (Flores et al., 2014;
Nelson et al., 2007); we thus refer to‘‘Ago’’ staining below. Strikingly, we observed that Agos are
highly expressed in the nuclei of a subset of NSCs (Figure 4D, yel-
low arrows) while in other NSCs the expression of Agos is either
exclusively cytoplasmic (Figure 4D, white asterisk) or diffuse
throughout the cell (Figure 4D, gray arrow). Importantly, the pres-
ence of Agos in cell nuclei was validated using both Ago anti-
bodies (Figure S4F) and confirmed by subcellular fractionation
of proteins from telencephalic extracts (Figure S5D). We also
observed a nuclear enrichment of Agos in neurons located in
the deep brain parenchyma, strikingly associated with the nu-
clear localization of neuronal microRNAs such as miR-128 (Fig-
ures S5A and S5B). Notably, the presence of Agos in nuclei
was restricted to adult stages, as Agos are exclusively located
in the cytoplasm of juvenile NPCs and neurons (Figure S5C).
Focusing on NSCs, we could show that, like miR-9, nuclear
Ago staining is significantly associated with quiescence and
we rarely see Agos in the nucleus of aNSCs (Figures S5E and
(legend on next page)
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S5F). Importantly, we also observed a strong association be-
tween the localization of Agos and miR-9 (c2 p value < 0.01) (Fig-
ure 4C): in miR-9-expressing qNSCs Agos are mostly found in
the nucleus (Figure 4D, yellow arrows), while in miR-9-negative
NSCs Agos are mostly cytoplasmic (Figure 4D, white asterisk
and gray arrow). Lastly, and remarkably, when we knock down
miR-9 we find a significant reduction in the proportion of NSCs
displaying high levels of Agos in the nucleus (control MO =
29% ± 8%; miR-9 MO = 7% ± 4%) (Figures 4E and 4F). By
contrast, we still observe a nuclear localization of Agos in
neuronal cells of the parenchyma, demonstrating that this effect
is specific to ventricular cells (Figure 4E, asterisks). This further
strengthens the correlation between nuclear miR-9 and nuclear
Agos; yet, based on these data, we cannot rule out the possibility
that the change of Ago localization upon miR-9 kd is an indirect
result of the increase in aNSCs number, which never have
nuclear Agos.
Ago Proteins Actively Shuttle between the Cytoplasm
and Nucleus that Impacts miR-9 Localization
To test the biological relevance of nuclear Agos in link with the
control of NSC quiescence, we first examinedwhether active nu-
clear/cytoplasmic shuttling of Agos occurs in vivo in qNSCs.
Recently, an essential protein component of the RISC, TNRC6A
(GW182), was shown to shuttle Ago2 between the cytoplasm
and the nucleus in human HeLa cells, while being re-cycled
out of the nucleus in an Exportin 1-dependent manner (Nishi
et al., 2013). We cloned a region spanning two of the GW regions
of the zebrafish tnrc6a gene (Figure 5A) and fused it with a GFP
tag. These two GW domains were previously demonstrated to
mediate binding of TNRC6A to Ago proteins in mammals (Eulalio
et al., 2008). We confirmed by co-immunoprecipitation experi-
ments in zebrafish embryos that the GFP-fused protein fragment
binds both overexpressed FLAG-tagged Ago2 and endogenous
zebrafish Ago proteins (Figure S6A). Moreover, overexpression
of this construct in embryos dose-dependently interferes with
miRNA silencing as shown in sensor assays (Figure S6B). Impor-
tantly, the TNRC6 fragment lacks a nuclear localization signal,
hence is unable to enter into the nucleus thus acting as a domi-
nant-negative TNRC6 (DN-TNRC6) cytoplasmic Ago-trap. To
preferentially target qNSCs, we placed this construct under the
promoter of the Notch-target gene her4 (her4:dn-tnrc6-gfp)
and electroporated it into the VZ of the adult pallium. In contrastFigure 4. miR-9 Is Nuclear in Mature qNSCs and Is Significantly Assoc
(A) Representative image of ISH for miR-9 (magenta) and double immunostaining
blue) highlighting the presence of miR-9 in the nucleus of qNSCs (yellow arrow)
(B) Sections through the medial region of the dorsal telencephalic ventricle of a 48
miR-9 (magenta) alone (top) and together with DAPI counterstaining in gray (bott
(C) Proportion of cells showing strong nuclear localization of Ago (blue) or most
populations, illustrating the association between nuclear Ago localization and mi
(D) ISH of miR-9 (magenta) and double fluorescent immunostaining for gfap:GFP
blue). Strong nuclear Ago localization is observed in miR-9+ NSCs (yellow arrows)
gray arrow). Scale bar, 20 mm.
(E) Double fluorescent immunostaining for gfap:GFP (green) and Ago (light blue) w
when compared to controls (top). NSCswith strong nuclear Ago staining (yellow ar
in neuronal cells is not affected by miR-9 kd (white asterisks). Scale bar, 10 mm.
(F) Quantification of the percentage of NSCs displaying a strong nuclear Ago s
Bonferroni post hoc correction. Data are represented as mean ± 95% CI; n = 3 b
1390 Cell Reports 17, 1383–1398, October 25, 2016to GFP, the DN-TNRC6-GFP fusion protein localizes mostly
cytoplasmically (Figure 5B, white arrow). Strikingly, Agos were
rarely nuclear in the NSCs that received her4:dn-tnrc6-gfp
(12% ± 8%; Figure 5B, white arrow), as opposed to NSCs
electroporated with the control her4:gfp (64% ± 5%; Figure 5B,
yellow arrow) thus confirming cytoplasmic trapping of Agos (Fig-
ures 5B and 5C). Additionally, miR-9 expression is completely
absent from the nuclei of the RG electroporated with her4:
dn-tnrc6-gfp (Figures 5D and S6C). Next, in a reciprocal experi-
ment, we inhibited Exportin 1 by injecting Leptomycin B (LMB)
into the brain ventricle. This treatment led to a significant in-
crease in NSCs displaying a strong nuclear Ago signal (Figure 5E,
yellow arrowheads; quantified in Figure 5F) thus establishing that
Agos can be transported to and maintained in the nucleus. LMB
administration concomitantly increased the number of cells dis-
playing a strong nuclear signal for miR-9 (Figures S6D and S6E).
In sum, we were able to demonstrate that an active shuttling of
Agos does indeed occur in vivo in NSCs, and specifically, their
nuclear export is dependent on Exportin-1 and their nuclear
import requires an interaction with TNRC6. Moreover, our data
also indicate that the presence of miR-9 in the nucleus is reliant
on nuclear Agos.
TheNuclear Localization ofmiR-9/Agos Is Necessary for
NSC Quiescence
Next, we wanted to evaluate whether manipulating the ratio of
nuclear to cytoplasmic Agos in NSCs impacts cell state. To do
this, we assessed the levels of NSC activation in the LMB-treated
and her4:dn-tnrc6-gfp-electroporated brains. In the context
of LMB-treated brains, the increased nuclear concentration of
Agos and miR-9 was correlated with a significant increase in
NSC quiescence (Figures 5E and 5G). In epistasis experiments,
this increase in quiescence was rescued by injection of miR-9
vivoMO, thus establishing a causal link between maintaining
miR-9/Agos complexes in the nucleus and the quiescent state
(Figure 5H). By contrast, we found that NSCs overexpressing
DN-TNRC6 were 2.5-fold more likely to enter into the cell cycle
when compared with control NSCs expressing GFP (Figures
5B and 5I). Notably, the fold increase in NSC activation that
was reached upon expressing DN-TNRC6 matches the one
observed in conditions of miR-9 kd (Figure 2B). Moreover,
knocking down miR-9 in conditions in which Ago/miR-9 com-
plexes are excluded from the nucleus, via application of theiated with the Nuclear Localization of the RISC Effector Ago
for PCNA (light blue) and GS (green) with nuclear DAPI counterstaining (dark
and not in the nucleus of aNSCs (red arrow). Scale bar, 10 mm.
hpf embryo, a 1 mpf juvenile, and a 3 mpf adult zebrafish illustrating an ISH of
om). Scale bar, 5 mm.
ly cytoplasmic localization of Ago (light gray) in miR-9+ versus miR-9 NSCs
R-9 expression.
(green) and Ago (ab57113, light blue) with nuclear DAPI counterstaining (dark
in contrast to cytoplasmic Ago localization in miR-9 NSCs (white asterisk and
ith nuclear DAPI counterstaining (dark blue) in conditions of miR-9 kd (bottom)
rowheads) are lost in miR-9MO-treated brains, while the nuclear signal for Ago
ignal 2 dpi of the control or miR-9 vivoMO. **p < 0.01; one-way ANOVA with
rains per condition.
Figure 5. Active Nucleo-Cytoplasmic Shuttling of Ago and miR-9 Impacts the Quiescent State of NSCs
(A) Scheme of the zebrafish TNRC6 protein with the cloned GW-rich Ago binding domain highlighted in purple.
(B) Triple immunofluorescence of GFP (green), Ago (magenta), and PCNA (light blue) with nuclear DAPI counterstaining (dark blue) on a representative cell
electroporated with a control construct (her4:gfp, top, yellow arrow) or the dominant-negative TNRC6 (DN-TNRC6) construct (her4:dn-tnrc6a-gfp, bottom, white
arrow). Scale bar, 5 mm.
(legend continued on next page)
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miR-9 vivoMO after electroporation of DN-TNRC6, does not
show an additive effect on proliferation (Figure 5J). This second
epistasis experiment further indicates that nuclear miR-9 is
indeed the active miR-9 pool in NSC quiescence control. Alto-
gether, these data suggest that Agos and miR-9 require each
other to be actively and concomitantly shuttled from the nucleus
to the cytoplasm in a TNRC6-dependent manner, and their sub-
cellular localization impacts cell state. In addition, their presence
in the nucleus is coupled with increased levels of quiescence.
Nuclear miR-9 and Ago Localization Are Conserved in
Quiescent NSCs of the Adult Mouse Brain
Adult NSCs in the zebrafish and mammalian pallium share mo-
lecular and cellular similarities, including their dependence on
Notch signaling for quiescence (Than-Trong and Bally-Cuif,
2015), suggesting that themiR-9/Ago process discovered above
may also be shared. To address this, we examined whether the
nuclear localization of miR-9 and Agos is conserved and linked
with quiescence control in adult mouse NSCs. At a global level,
ISH experiments revealed the expression of miR-9 to be high in
the SEZ and DG, the two known areas of constitutive neurogen-
esis in the adult mammalian brain (Figure S7A). No signal was
obtained using a control scrambled probe, demonstrating the
specificity of our staining (Figure S7B). We then analyzed the
expression of miR-9 in conjunction with GFAP and Sox2,
a SRY-related HMG box family member transcription factor
demonstrated to be expressed in NSCs (quiescent and acti-
vated) of the DG and SEZ (Hsieh, 2012; Suh et al., 2007). Strik-
ingly, we observe miR-9 in the nucleus of a subset of NSCs in
both regions (Figures 6A and 6B, yellow arrows). In contrast to
what we observed in zebrafish, miR-9 appears to be additionally
expressed in other cell types, although with a cytoplasmic local-
ization. Very infrequently Sox2+ NSCs are found to be actively
proliferating and express Ki67, however, like in zebrafish, we
did not detect miR-9 in the nucleus of these aNSCs (Figure S7C).
We also compared the proportion of GFAP+ Sox2+NSCs that ex-
press miR-9 in the nucleus between young (2-month-old) and
older (10-month-old) mice in the DG. Interestingly, we observed
a significant increase in miR-9 nuclear localization, suggesting a
maturation-associated shift in the subcellular localization of
miR-9 (Figure 6C). Overall, this in vivo data suggest that, like in
zebrafish NSCs, nuclear miR-9 is associated with a mature
quiescent NSC state in the mouse brain.
In the DG, BMP signaling maintains NSC quiescence and
cultured NSCs from mice and rats have been shown to enter
into a state of reversible cell-cycle arrest when treated with(C) Quantification of the data from (B), showing the percentage of electroporated c
condition.
(D) Percentage of cells electroporated with the her4:gfp (top) or her4:dn-tnrc6-
cytoplasm (gray) or absent (light blue); n = 10 brains per condition.
(E) Triple fluorescent immunostaining of gfap:GFP (green), Ago (magenta), and P
injection of LMB (bottom) or a MeOH control (top). Yellow arrowheads highlight N
(F and G) Quantification of data from (E) 24 hpi with LMB or MeOH as a control; n =
signal. (G) Percentage of aNSCs (PCNA+, gfap+) among NSCs (gfap+).
(H) Percentage of aNSCs (PCNA+, gfap+) among NSCs (gfap+) upon combination
(I) Quantification of the data from (B) of the percentage of GFP+ aNSCs out of to
(J) Percentage of aNSCs (MCM2+, GFP+) out of total NSCs (GFP+) after electropo
MO injections. n = 7 brains per condition. *p < 0.05, **p < 0.01; one-way ANOVA
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scriptomic analysis demonstrated that this cell-cycle arrest is
equivalent to endogenous quiescence (Martynoga et al., 2013)
thus making these cells an ideal tool in which to probe the sub-
cellular localization of Agos and miR-9 upon synchronous quies-
cence entry. For our analysis, we utilized in vitro NSCs isolated
from the DG of adult mice (AH-NSCs). When cultured in the
presence of the mitogen epidermal growth factor (EGF), these
AH-NSCs are actively proliferating as demonstrated by the
expression of the cell-cycle marker MCM2 (Figure S7D). These
cells, when cultured for 3 days without EGF and in the presence
of BMP4, downregulateMCM2and upregulate GFAP expression
(Figures S7D and S7E). We could observe that proliferating
NSCs tend to display low levels of Agos and miR-9 inside their
nuclei, while quiescent AH-NSCs display a dramatic increase
in the nuclear concentration of Ago2 and miR-9 (Figure 6D).
Quantitative analysis shows that up to 60% of AH-NSCs harbor
strong nuclear signals for Agos andmiR-9when they are induced
to quiescence by BMP4 (Figures 6E and 6F). The increase in nu-
clear localization of these two factors was confirmed by auto-
mated quantification of relative signal intensities in cytoplasmic
and nuclear compartments (Figure 6G). By contrast, we did not
detect any significant change in total levels of Ago2 protein
(Figure S7F). Altogether, these in vivo and in vitro data point to
a conserved association between nuclear Agos and miR-9 with
quiescence in murine NSCs.
DISCUSSION
Our study identifies a microRNA, miR-9, as a critical player in the
regulation of zebrafish pallial NSCs quiescence, a defining and
protective feature of adult tissue stem cells (Cheung and Rando,
2013). Other microRNAs have been shown to be pivotal in regu-
lating the proliferative behavior of adult tissue stem cells, such as
in the muscle (Cheung et al., 2012; Crist et al., 2012; Sato et al.,
2014) or skin (Wang et al., 2013). Interestingly, in our case, we
also observed that miR-9 is expressed in only half of the qNSCs.
Further, BrdU pulse-chase experiments demonstrated that, after
cell division, there is a short refractory period after which miR-9
expression is progressively induced in NSCs. The proportion of
miR-9-expressing cells in the BrdU label-retaining NSCs never
exceeds this of the overall NSCs population, indicating that
miR-9 expression highlights a transitory phase qNSCs shuttle
through. Our data thus highlight the importance of division his-
tory and temporal competence for the establishment of miR-9
expression in qNSCs and identify miR-9 as a molecular markerells withmostly nuclear (blue) or cytoplasmic (gray) Ago signal; n = 10 brains per
gfp construct (bottom) in which miR-9 is detected in the nucleus (dark blue),
CNA (light blue) with nuclear DAPI counterstaining (dark blue) after ventricular
SCs with a strong nuclear Ago signal. Scale bar, 20 mm.
5 brains per condition. (F) Percentage of NSCs (gfap+) with strong nuclear Ago
of LMB or MeOH injections with vivoMO injections. n = 4 brains per condition.
tal GFP+ NSCs; n = 10 brains per condition.
ration with the control her4:gfp or her4:dn-tnrc6-gfp construct and subsequent
with Bonferroni post hoc correction. Data are represented as mean ± 95% CI.
Figure 6. Nuclear Localization of miR-9 and Ago2 Also Correlates with Quiescence in Adult Mouse NSCs
(A and B) Representative high-magnification two-dimensional images of the 10-month DG (A) and SEZ (B) on the XY (top) and YZ (bottom) axes (yellow line =
position of the YZ image) with Sox2 (light blue) and GFAP (green) immunofluorescence, miR-9 ISH (magenta), and a nuclear DAPI counterstain (gray). Scale bars,
10 mm.
(C) Percentage of NSCs (Sox2+, GFAP+) with nuclear miR-9 in the DG of 2- and 10-month mouse brains; n = 2 brains per age. *p < 0.05; one-way ANOVA with
Bonferroni post hoc correction. Data are represented as mean ± 95% CI.
(legend continued on next page)
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Figure 7. Model for Ago/miR-9 Complexes in Regulating NSCs Quiescence
(A) miR-9 is concentrated in the cytoplasm of all juvenile NSCs (qNSCs and aNSCs). In the adult, miR-9 is concentrated in the nucleus of 50% of the qNSCs.
Adult qNSCs cycle between miR-9+ and miR-9 states.
(B) In adult qNSCs (left), Ago (light purple)/miR-9 (magenta) complexes are actively shuttled into the nucleus by TNRC6 proteins (dark green). Enhanced transport
of Ago/miR-9 complexes into the nucleus anchors the NSCs in quiescence via directly or indirectly activating her4 expression in concert with Notch3 and through
other unknown mechanisms, perhaps by influencing chromatin state. Upon transport of Ago/miR-9 complexes into the cytoplasm, the NSC is activated (right)
and miR-9 is no longer detectable, demonstrating that TNRC6-mediated shuttling of Ago/miR-9 is necessary for balancing the quiescent versus activated
NSC state.of a heterogeneity among qNSCs. Previous studies applying ge-
netic labeling and lineage tracing have demonstrated that NSCs
in the adult mouse DG are also heterogeneous in their activation
potential and contribution to long-term neurogenesis (Giachino
and Taylor, 2014; Lugert et al., 2010). Unveiling the precise prop-
erties linked with miR-9 expression, in terms of differential mo-
lecular control of activation and fate potential upon division will
ultimately help understanding the establishment of heterogene-
ity within qNSCs and its functional significance for NSCs popu-
lation dynamics.
Many similarities anddifferencesbetween the nature and regu-
lation of embryonic NPCs and adult NSCs have been identified
(Urba´n and Guillemot, 2014), however, the modifications in
stem cell properties and molecular control between juvenile
and adult stages are still rather understudied. Interestingly, a
recent study revealed a progressive change in the expression
of cell-cycle regulators in BLBP-positive RG during post-natal
stages inmice, directly influencing the competence of these cells
to be transformed by oncogenes (Mun˜oz et al., 2013). Moreover,
a change in microRNAs signature occurs in muscle satellite stem
cells between juvenile and adult stages and correlates with a(D) Immunofluorescence for Ago2 (magenta) (left) and ISH for miR-9 (light blue) (ri
(bottom) adult hippocampal neural stem cells (AH-NSCs). Scale bars, 10 mm.
(E and F) Percentage of NSCs with high nuclear concentration of Ago2 (E) or miR
(G) Relative distribution of Ago2 (left) and miR-9 (right) signal intensities in the cyto
confocal fields taken from 3 independent coverslips (5 fields/coverslip) in each c
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provide important molecular insights on this transition. First, we
show that the relative expression of themiR-9 primary transcripts
changes progressively from the embryo to the adult. Second, in
the adult zebrafish pallium, miR-9 is exclusively expressed in
qNSCs and maintains this cell state, which differs from the
embryonic situation where miR-9 is expressed in proliferating
NPCs and favors neurogenic activity (Bonev et al., 2012; Coolen
et al., 2012; Shibata et al., 2008). Finally, this functional change is
associated with a modification of miR-9 subcellular localization.
Indeed, whereasmiR-9 is detected cytoplasmically in embryonic
and juvenileNPCs,weunexpectedly observed aconcentration of
miR-9 inside the nucleus of qNSCs, in tight correlation with
the presence of the effector Ago proteins (Figure 7A). Juvenile
NPCs already display quiescence characteristics (Alunni et al.,
2013; Dirian et al., 2014), thus, in addition to pinpointing an
aged-dependent change in regulatory mechanisms of qNSCs,
these data reinforce nuclear miR-9 expression as establishing
a particular phase of the quiescence cycle, specific to mature
NSCs. In the mouse DG, we observed an age-associated in-
crease in theproportionofNSCsharboringmiR-9 in their nucleus.ght) and a nuclear DAPI counterstain (gray) on proliferating (top) and quiescent
-9 (F) in proliferation-promoting or quiescence-promoting conditions.
plasm (dark gray) and nucleus (blue) in proliferating or quiescent NSCs; n = 15
ondition; total proliferating NSCs = 2,411, total quiescent NSCs = 860.
However, at this point, because the temporal scales appear
different, it remains an open question whether or not the same
mechanisms are at play in the two species. Elucidating whether
systemic factors are present that are capable of affecting
miR-9 localization in an age-dependent fashion, or alternatively,
if a NSC intrinsic clock could determine the switch of miR-9 pref-
erential localization will shed more light on the mechanisms un-
derlying the establishment and regulation of a mature NSC pool.
Although the canonical mechanism by which the Ago/RISC
mediates gene expression is via mRNA silencing in the cyto-
plasm, several studies, largely performed in vitro, highlighted
the presence of Ago complexes in the nucleus, although the
precise mechanism of their shuttling is not fully understood
(Nishi et al., 2013, 2015; Schraivogel and Meister, 2014; Schrai-
vogel et al., 2015; Matsui et al., 2015). Here, we provide evi-
dence for the active nuclear/cytoplasmic shuttling of Agos
in vivo in NSCs, and moreover, we show that this transport
depends on the interaction of Agos with TNRC6 proteins. Addi-
tionally, we observed a surprising specificity of nuclear Agos
to the population of qNSCs expressing nuclear miR-9 thus
revealing their interdependency and overall indicating that
Ago complexes that translocate to the nucleus must be loaded
with miR-9. As nuclear localization of miR-9 and Ago is specific
to qNSCs, and more precisely to a subset of qNSCs at any
given time, it would be interesting to resolve how their nu-
clear/cytoplasmic shuttling is regulated in concert with the
cell-cycle status of these cells and potentially in response to
environmental cues from the neurogenic niche. Additionally,
in-depth analysis of other NSC-expressed microRNAs and
nuclear RISC components will be important to define this
regulatory pathway.
Some classes of small non-coding RNAs such as PIWI-inter-
acting RNAs (piRNAs) and small interfering RNAs (siRNAs) are
recognized as regulating gene expression in both the cyto-
plasm and nucleus, however, a potential regulatory role for
microRNAs outside of the canonical cytoplasmic pathway
has just started to be explored (Castel and Martienssen,
2013; Schraivogel and Meister, 2014). Moreover, whether their
presence in the nucleus is functional or rather just a mechanism
for passive storage is still heavily debated (Gagnon et al., 2014;
Olejniczak et al., 2013). In this study, we show that the dynamic
transport of Ago and miR-9 functionally influences the activa-
tion status of the cell. Specifically, trapping Ago/miR-9 in the
cytoplasm increases NSCs activation rate, mimicking miR-9
kd phenotype. Conversely, increasing miR-9 and Agos nuclear
concentration using LMB significantly decreased NSC activa-
tion, a phenotype that is reversed by blocking miR-9. Alto-
gether, this data supports an active role for nuclear Ago/
miR-9 complexes in qNSCs (Figure 7B). Interestingly, and in
line with our results, in vitro studies have demonstrated that
nuclear Ago/microRNA complexes repress the transcription of
cell-cycle activators thus leading to cell-cycle arrest (Ben-
hamed et al., 2012) opening to the intriguing possibility that
an analogous nuclear Ago mechanism could be occurring
in adult NSCs. Unravelling this mechanism and identifying
miR-9/Ago targets in the nucleus will also shed light on the
functional synergy between miR-9 and Notch signaling activity
in the control of adult NSCs quiescence.EXPERIMENTAL PROCEDURES
Animals
Wild-type (AB) and Tg(gfap:gfp)mi2001 (Bernardos and Raymond, 2006) zebra-
fishweremaintained using standard protocols and in accordancewith Institute
Guidelines for Animal Welfare. All experiments performed on zebrafish con-
formed to the official standards of the Department of Essonne (agreement
#A91-577). Three- to six-month-old adult fish were used for analysis unless
otherwise stated.Micewere housed, bred, and treated according to the guide-
lines approved by the Home Office under the Animal (Scientific Procedures)
Act 1986. All experimental procedures involving mice have been approved
by the Animal Welfare and Ethical Review Panel of the National Institute for
Medical Research.
BrdU Pulse-Chase and LY411575 Treatments
BrdU (1mM, Sigma) was applied to the fishwater at 28C in the dark. Fishwere
subsequently transferred to a tank with fresh water during the chase period.
LY411575 (10 mM, Stemgent) or DMSO carrier alone (0.4%–0.5%) was applied
to the fish water for 48 hr at 28C in the dark and refreshed once after 24 hr.
Ventricular Micro-injections and Electroporation
Micro-injections into the adult pallial ventricle were performed on anaesthe-
tized fish as described (Rothenaigner et al., 2011). vivoMOs (Gene-tools)
were injected at a concentration of 50 mM (Table S1). Leptomycin B (Sigma)
was resuspended in MeOH and fish were injected with either 2.0 nL of
100 nM LMB or MeOH (70%) and brains were analyzed 1 dpi. For electropo-
ration, plasmid DNA was diluted to 2–4 mg/mL in TE pH8.0 and injected into
the ventricle. Fish were then administered two electric pulses (70 V, 50 ms
width, 1,000 ms space). For epistasis experiments, electroporation was
carried out 2 hr prior to vivoMO injections.
In Situ Hybridization
Adult zebrafish brains or embryos were fixed in 4% paraformaldehyde (PFA)
overnight at 4C. Mice were transcardially perfused with saline followed by
4% PFA and brains were dissected and postfixed with 4% PFA for 2 hr at
4C. In situ hybridization (ISH) with DIG-labeled RNA probes were performed
as described (Alunni et al., 2013). MicroRNA ISH using LNA probes (Exiqon)
was performed according to Leucht et al. (2008) on zebrafish embryos and
on free-floating vibratome sections of the zebrafish adult telencephalon or
mouse brain. MicroRNA ISH using the LNA 20-O-Me modified probes (Ribo-
task) was performed on 50 mm free-floating vibratome sections following
manufacturer instructions. miR-9 ISH on cultured mouse cells was performed
as described (Lu and Tsourkas, 2009). All in situs were revealed using fast red
(Sigma) or NBT/BCIP (Sigma). ISH probes are listed in Table S2.
Immunohistochemistry
Fluorescent immunohistochemistry on zebrafish brain sections was per-
formed as described (Chapouton et al., 2010). Perfused mouse adult brain
tissue was sectioned coronally at 40 mm with a vibratome and subsequent
immunohistochemistry was performed as described (Andersen et al., 2014).
Immunohistochemistry on AH-NSCs was performed as described (Martynoga
et al., 2013). The primary antibodies used in this study are listed in Table S3.
For BrdU and PCNA staining, sections were incubated in either 2 N HCL for
30 min at 37C or 13 HistoVT One (Nacalai Tesque) for 1 hr at 65C. Goat
or donkey secondary antibodies coupled to AlexaFluor dyes (Invitrogen) or
Cy3/Cy5 dyes (Jackson Labs) were used (1:1,000) with DAPI (5 mg/mL) counter-
stain for nuclei.
qRT-PCR
Total RNA enriched for small RNAs were extracted from adult telencephali
(pool of 4), 1 month post-fertilization whole brains (pool of 5), and whole
embryos (pool of 50–100) using the High Pure miRNA Isolation Kit (Roche).
The following reagents were used for detection of the primiR-9 transcripts: Su-
perscript II kit (Invitrogen) with Random Hexamer Primers (Thermo Scientific)
for cDNA synthesis and LightCycler FastStart DNA Master SYBR Green I
(Roche) for qRT-PCR. Primers used for qRT-PCR are listed in Table S4. Effi-
ciencies of each primer pair was evaluated by performing a dilution seriesCell Reports 17, 1383–1398, October 25, 2016 1395
experiment. The following reagents were used for detection of mature miRs:
miRCURY LNA Universal cDNA Synthesis Kit (Exiqon) for cDNA synthesis
and miRCURY LNA ExiLENT SYBR Green master mix (Exiqon) for qRT-PCR.
For each transcript/miR, two biological and two technical replicates were per-
formed using the LightCycler 2.0 Carousel-Based System (Roche). Crossing
points were calculated using the LightCycler 4.0 software (Roche) (normalized
to b-actin and gapdh for the primary transcripts and U6 for the mature miRs)
and all relative expression analysis was done using the REST (Pfaffl et al.,
2002) software tool that determines significant differences between control
and sample groups-based crossing points using a randomization algorithm.
AH-NS Cell Culture
AH-NSCs were isolated from 6-week-old C57Bl6 mice using the neural tissue
dissociation kit (Miltenyi Biotec) and cultured as described previously (Marty-
noga et al., 2013). Briefly, cells were plated at a density of 30,000 cells/cm2
onto laminin coated coverslips (2 mg/mL) in normal NSC proliferation medium
(EGF and FGF at 20 ng/mL; Peprotech). To induce quiescence, fresh NSCme-
dium without EGF andwith 20 ng/mL BMP4 (R&D Systems) was added. BMP4
containing media was changed daily. Cells were fixed in 4% PFA for 10 min.
Imaging, Cell Counting, and Statistics
Images were taken using a Zeiss LSM700 (Zeiss) confocal microscope using
203, 403 (oil), or 633 (oil) objectives. Images were processed using the
ZEN (Zeiss) and Fiji software. Cell counts on zebrafish brains were carried
out manually on 50 mm z stacks from three serial sections from telencephali
with n = 3 telencephali per condition unless otherwise stated. Imaris (Bit-
plane-Oxford Instruments) was used for all mouse DG cell counts. Briefly,
spots were added automatically in the Sox2 channel to identify all Sox2+ cells.
To determine nuclear miR-9, a filter was added to the spots identifying Sox+
cells based on the center intensity of the miR-9 channel. A center intensity
of >55 was determined to be nuclear miR-9 expression. Analysis of Ago2
and miR-9 expression in AH-NSCs was carried out using the Fiji/ImageJ
software. The subcellular distribution of Ago2 and miR-9 was analyzed using
the Intensity Ration Nuclei Cytoplasm Tool plugin. For all analyses, n = 3 inde-
pendent wells per sample with five confocal fields analyzed per well. For all
quantitative experiments, statistical analysis was carried out using Excel and
InVivoStat (Clark et al., 2012). Experimental data are expressed as means ±
95% confidence interval. Associations were determined using c2 tests for as-
sociation. Comparisons between groups were made using one-way ANOVAs
followed by Bonferroni post hoc correction.
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